Novo Nordisk AS (NVO)
105.06
+2.43
(+2.37%)
USD |
NYSE |
Nov 22, 16:00
105.08
+0.02
(+0.02%)
After-Hours: 20:00
Novo Nordisk Stock Buybacks (Quarterly): 385.57M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 385.57M |
June 30, 2024 | 1.071B |
March 31, 2024 | 413.08M |
December 31, 2023 | 1.400B |
September 30, 2023 | 895.11M |
June 30, 2023 | 1.300B |
March 31, 2023 | 749.77M |
December 31, 2022 | 1.174B |
September 30, 2022 | 532.71M |
June 30, 2022 | 1.032B |
March 31, 2022 | 675.36M |
December 31, 2021 | 1.202B |
September 30, 2021 | 530.86M |
June 30, 2021 | 881.48M |
March 31, 2021 | 479.84M |
December 31, 2020 | 823.87M |
September 30, 2020 | 546.06M |
June 30, 2020 | 815.47M |
March 31, 2020 | 397.13M |
December 31, 2019 | 749.37M |
September 30, 2019 | 417.15M |
June 30, 2019 | 683.90M |
March 31, 2019 | 448.82M |
December 31, 2018 | 700.50M |
September 30, 2018 | 523.62M |
Date | Value |
---|---|
June 30, 2018 | 526.81M |
March 31, 2018 | 714.99M |
December 31, 2017 | 629.25M |
September 30, 2017 | 751.19M |
June 30, 2017 | 575.49M |
March 31, 2017 | 608.13M |
December 31, 2016 | 594.31M |
September 30, 2016 | 525.92M |
June 30, 2016 | 562.63M |
March 31, 2016 | 555.17M |
December 31, 2015 | 659.70M |
September 30, 2015 | 749.74M |
June 30, 2015 | 573.47M |
March 31, 2015 | 575.40M |
December 31, 2014 | 696.46M |
September 30, 2014 | 662.41M |
June 30, 2014 | 630.80M |
March 31, 2014 | 626.35M |
December 31, 2013 | 541.33M |
September 30, 2013 | 523.78M |
June 30, 2013 | 907.18M |
March 31, 2013 | 507.02M |
December 31, 2012 | 259.71M |
September 30, 2012 | 290.83M |
June 30, 2012 | 1.005B |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
385.57M
Minimum
Sep 2024
1.400B
Maximum
Dec 2023
802.77M
Average
782.62M
Median
Stock Buybacks (Quarterly) Benchmarks
Ascendis Pharma AS | -- |
Amgen Inc | -- |
AstraZeneca PLC | 77.00M |
Viking Therapeutics Inc | -46.66M |
Evaxion Biotech AS | -- |